You guys need to check out this bio pharm stock Cormedix CRMD I bought shares of this at an average of .61 cents in October and its now at $1.70. They have a product called Neutrolin which is already successful in Europe and is seeking FDA approval in the states. Institutions are buying this up such as Blackrock, and Vanguard group as well as insiders. This stock has been my best performing over the last 3 months. This is an extremely strong buy for me and im going all in on this.
Brief:CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced the topline results of the interim analysis of the Company's Phase 3 LOCK-IT-100 study for Neutrolin® as a catheter lock solution in hemodialysis patients.
Catalyst: Unblinding of trail results,FDA approval, buyout/partnership
Cormedix Inc. Announces Highly Statistically Significant Topline Results For Neutrolin(R) From The Interim Analysis Of The Phase 3 Lock-It-100 Study - Press Release - Digital Journal